Home : Unsafe Drugs : Provigil : MSN Newsfeeds
Provigil - MSN Newsfeeds
- Seattle Post Intelligencer - In other corporate news, federal regulators sued Cephalon Inc., contending the biotechnology company illegally blocked the sale of low-cost generics to safeguard its biggest money making drug, Provigil. The drug is used to treat excessive sleepiness ...
- BusinessWeek - In other corporate news, federal regulators sued Cephalon Inc., contending the biotechnology company illegally blocked the sale of low-cost generics to safeguard its biggest money making drug, Provigil. The drug is used to treat excessive sleepiness ...
- Daily Express - They included “the clear”, insulin, growth hormone, a testosterone cream and the stimulant modafinil. Everyone, it seemed, paid the price apart from Conte. In 2006 Korchemny confessed to his involvement. He was put on probation for a year ...
- Phramalive.com - ... Trade Commission today filed a complaint in federal district court against Cephalon, Inc., a pharmaceutical company based in Frazer, Pennsylvania, for a course of anticompetitive conduct that is preventing competition to its branded drug Provigil ...
- Philadelphia Inquirer - The Federal Trade Commission filed a lawsuit yesterday against Cephalon Inc. over deals it struck with four makers of generic drugs that had challenged the patent on Cephalon's biggest drug, Provigil. The agreements, which the FTC said were worth ...
- CNBC - NEW YORK - Shares of Cephalon Inc. jumped Thursday as Wall Street brushed off concerns that a federal lawsuit could result in generic competition to sleep-disorder drug Provigil. The stock gained $3.98, or 6.9 percent, to $61.42. Shares have traded ...
- Reuters - The FTC said on Wednesday it was suing the Frazer, Pennsylvania-based drugmaker for signing deals that delay the sale of generic versions of its sleep disorder drug, Provigil. "This is part of doing business in America today," Baldino said in an ...
- MSN MoneyCentral - He said sales of the narcolepsy drug Provigil could continue declining in 2008, but expanded approvals for the chemotherapy drug Treanda and pain drug Fentora could offset those concerns. Leerink Swann & Co. analyst Gary Nachman voiced concern over ...
- MSN MoneyCentral - He said sales of the narcolepsy drug Provigil could continue declining in 2008, but expanded approvals for the chemotherapy drug Treanda and pain drug Fentora could offset those concerns. Leerink Swann & Co. analyst Gary Nachman voiced concern over ...
- CNBC - The FTC claims the patent dispute settlements for Provigil with Teva Pharmaceutical Industries Ltd., Ranbaxy Laboratories Ltd., Mylan Pharmaceuticals Inc., and Barr Laboratories Inc. were anticompetitive and monopolistic. In 2005 and 2006, Cephalon ...
- CNBC - SAN FRANCISCO (Thomson Financial) - The Federal Trade Commission on Wednesday filed a complaint against Cephalon Inc. for unlawfully blocking the sale of lower-cost generic versions of its branded drug Provigil, a treatment for sleepiness. The FTC ...
- RTT News - District Court for the District of Columbia challenging the validity of certain agreements entered into by the company in late 2005 and early 2006 to settle the Provigil (modafinil) (C-IV) patent infringement litigation and seeking to permanently ...
- RTT News - District Court for the District of Columbia challenging the validity of certain agreements entered into by the company in late 2005 and early 2006 to settle the Provigil (modafinil) (C-IV) patent infringement litigation and seeking to permanently ...
- RTT News - 2/13/2008 5:46:01 PM Cephalon Inc., (CEPH) issued a statement in response to a complaint filed today by the U.S. Federal Trade Commission or FTC in U.S. District Court for the District of Columbia challenging the validity of certain agreements ...
- CNBC - FTC ACCUSES CEPHALON OF PAYING 4 FIRMS TO REFRAIN FROM SELLING GENERIC PROVIGIL ... SAN FRANCISCO (Thomson Financial) - Katherine Hunt kh COPYRIGHT Copyright Thomson Financial News Limited 2007. All ...
- Reuters - Federal Trade Commission filed a lawsuit against Cephalon Inc (CEPH.O: Quote , Profile , Research ) on Wednesday, challenging deals that the company struck with generic drug makers to keep a cheaper copycat version of the sleep disorder drug Provigil ...
- Forbes - Copyright Thomson Financial News Limited 2007. All rights reserved. The copying, republication or redistribution of Thomson Financial News Content, including by framing or similar means, is expressly prohibited without the prior written consent of ...
- Forbes - District Court for the District of Columbia challenging the validity of certain agreements entered into by the company in late 2005 and early 2006 to settle the PROVIGIL(R) (modafinil) [C-IV] patent infringement litigation and seeking to permanently ...
- Forbes - The agreements, which the FTC said were worth $200 million,would prevent four companies from selling a generic version of the sleep disorder drug Provigil until 2012, the agency said. "Cephalon (nasdaq: CEPH - news - people ...
- Times Online - It’s called Modafinil, a commonly prescribed narcolepsy drug. You may wonder how students can afford to go out so often and consume so many costly chemicals. Let me enlighten you. A non-income-assessed loan is £3,385 a year minimum. It is fairly ...
Pages: Previous 1 2 3 4 5 6 7 ... Next






